← Back to Search

Other

Contingency Management for Cannabis Use Disorder in Adolescents

N/A
Recruiting
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
14 to 25 years of age.
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up collected at week 8
Awards & highlights

Study Summary

This trial will study the effects of cannabis use on the endocannabinoid system (ECS) and endogenous opioid system (EOS) in adolescents. The goal is to identify biomarkers that may help distinguish youth who relapse from those who remain sober.

Who is the study for?
This trial is for adolescents aged 14 to 25 who use cannabis at least twice a week over the past month. It's not open to those using other illicit drugs or opioids recently, with current psychosis, risk of suicide, intellectual deficiencies that affect consent understanding, without internet access for Zoom, or if they're intoxicated during evaluation.Check my eligibility
What is being tested?
The study is exploring how regular cannabis use affects young people's natural cannabinoid and opioid systems. By monitoring these biological markers in adolescents with Cannabis Use Disorder, researchers aim to identify patterns that could predict relapse or sustained sobriety.See study design
What are the potential side effects?
Since this trial involves observation and behavioral intervention rather than medication, traditional side effects are not applicable. However, participants may experience psychological discomfort discussing their substance use habits.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 14 and 25 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~collected at week 8
This trial's timeline: 3 weeks for screening, Varies for treatment, and collected at week 8 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cannabinoid levels in blood
Endocannabinoid levels in blood
Secondary outcome measures
Cannabis Craving
Endorphin levels in blood

Trial Design

1Treatment groups
Experimental Treatment
Group I: Contingency ManagementExperimental Treatment1 Intervention
Abstinence will be rewarded following a contingency management (CM) payment scale.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Contingency Management
2003
Completed Phase 2
~3220

Find a Location

Who is running the clinical trial?

Colorado Clinical & Translational Sciences InstituteOTHER
19 Previous Clinical Trials
1,430 Total Patients Enrolled
University of Colorado, DenverLead Sponsor
1,738 Previous Clinical Trials
2,149,496 Total Patients Enrolled
4 Trials studying Cannabis Use
712 Patients Enrolled for Cannabis Use

Media Library

Cannabis Use Clinical Trial 2023: Contingency Management Highlights & Side Effects. Trial Name: NCT05396638 — N/A
Contingency Management (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05396638 — N/A
Cannabis Use Research Study Groups: Contingency Management

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is my participation in this research endeavor permissible?

"This research endeavour is enrolling 30 adolescents and young adults who partake in cannabis consumption with a minimum frequency of twice per week. In order to be considered, all participants must lie between the ages of 14-25 years old."

Answered by AI

Is there an age restriction for eligibility in this experiment?

"Adolescents aged 14-25 years old are welcome to apply for this clinical trial."

Answered by AI

Has this investigation opened its doors to new participants?

"According to medical research posted on clinicaltrials.gov, this trial is actively looking for volunteers and has been open since October 13th 2022 with the latest update occurring one day later."

Answered by AI

What is the current enrollment limit for this research initiative?

"Affirmative. Clinicaltrials.gov hosts details of this clinical trial, which was first uploaded on October 13th 2022, and is actively looking for 30 participants across a single medical centre."

Answered by AI

Who else is applying?

What state do they live in?
Colorado
How old are they?
18 - 65
What site did they apply to?
University of Colorado Anschutz Medical Campus
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
How many prior treatments have patients received?
0
Recent research and studies
clinicaltrials.govStudy
Characterization of Endocannabinoid and Endogenous Opioid Levels in Adolescents With Cannabis Use Disorder
2022. "Characterization of Endocannabinoid and Endogenous Opioid Levels in Adolescents With Cannabis Use Disorder". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05396638.
~2 spots leftby Jun 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top